Press Release

Immunoassay Market | 2021 Size, Share, Trends, Growth, Growth Insights, Regional Analysis, Regional Outlook, Key Players, Industry Analysis, Covid-19 Impact.

Immunoassay Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players And Regional Forecast latest study published by Fortune Business Insights. Global ”Immunoassay Market“ 2021 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Immunoassay Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Immunoassay market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. Regionally, this report categorizes the production, apparent consumption, export and import of Immunoassay in North America, Europe, China, Japan, Southeast Asia and India.

The Global Immunoassay market 2021 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Immunoassay Market Share analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analysed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. For each manufacturer covered, this report analyses their Immunoassay manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

Request a Sample Copy of the Research Report:

Key Players Covered:

The major companies in the global immunoassay report include Abbott, bioMérieux SA, Ortho Clinical Diagnostics, Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Merck KGaA, Agilent Technologies, Inc., DiaSorin S.p. A, Beckman Coulter Inc., and other prominent players.

Global Immunoassay Market Highlights:

The Immunoassay Market report offers an in-depth analysis of the Immunoassay industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Immunoassay market concentration, and maturity analysis is elaborated in this report.

Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers.

The outbreak of covid-19 in the global market has made companies uncertain about their future scenario as the prolonged lock-down finds a serious economic slump. The latest survey on COVID-19 Outbreak-Global Immunoassay Market is conducted to provide hidden gems performance analysis. Essential growth factors and study of Basis points [BPS] have been discussed in the following report. Research Report explains a detailed overview of market dynamics, segmentation, product portfolio, business plans, and the latest development in the industry.

Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for Immunoassay market to figure out and study the market’s needs, market size, and competition.

Market Segmentation:

The global immunoassay market can be segmented on the basis of products, technology, applications, end-users, and region. In terms of products, the market can be segmented into instruments and consumables. Based on the technology, the market can be segmented into radioimmunoassay, Enzyme-linked immunosorbent assays (ELISA), fluoroimmunoassay, chemiluminescence immunoassay, and others. Based on the applications, the market can be segmented into cardiology, oncology, autoimmune diseases, infectious diseases, therapeutics, and others. Based on the end-user, the market can be segmented into biotechnology & pharmaceutical industries, clinical diagnostic laboratories, academic & research institutes, and others.

Geographically, the immunoassaymarket can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Key Insights:

  • Key Industry Developments – Mergers, Acquisitions, and Partnerships
  • Prevalence of Infectious Diseases
  • Recent Immunoassay Research & Development Activities
  • New Product Launch

Regional Analysis:

Geographically, the global immunoassay market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region is likely to hold the largest share of the market and is anticipated to follow the same thrust over the forecast period owing to the increasing demand for technologically advanced products. Moreover, rising R&D grants from the government as well as private health care agencies contributing to the advancement of technology supporting the growth of the market. However, the immunoassay market in the Asia Pacific is expected to grow at highest rate due to the increase in the prevalence of infectious diseases, increased biotechnological research activities, and an increase in the healthcare expenditure of the region. Latin America and the Middle East & Africa are expected to show moderate growth during the forecast period.

Immunoassay Instrument Market Industry Developments

  • In January 2020, bioMérieux SA announced that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for clearance of the BIOFIRE Blood Culture Identification 2 (BCID2) Panel. The BIOFIRE BCID2 Panel includes several additional pathogens, an expanded list of antimicrobial resistance genes, and many revised targets compared to the existing BIOFIRE BCID Panel.
  • In April 2018, Siemens Healthcare GmbH Announced first installation of the Atellica immunoassay Solution with Aptio Automation in the United States. This product launch wad intended to expand the technologically advanced product in the U.S.
  • In April 2018, bioMérieux SA, announced the acquisition of Astute Medical Inc., involved in improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers. The acquisition was intended to enhance bioMérieux SA’s immunoassay biomarkers offerings.

Market Segmentation :

By Product

  • Instruments
  • Consumables

By Technology

  • Radioimmunoassay
  • Enzyme-Linked Immunosorbent Assays (ELISA)
  • Fluoroimmunoassay
  • Chemiluminescence Immunoassay
  • Others

By Applications

  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Therapeutics
  • Others

By End-Users

  • Biotechnology & Pharmaceutical Industries
  • Clinical Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

By Geography

  • North America (USA, Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Have Any Query? Ask Our Experts:

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Fortune Business Insights™

LinkedIn | Twitter | Blogs


Related Reports :

Immunomodulators Market

Immunomodulators Market Size

Immunomodulators Market Share

Immunomodulators Market Trends

Immunomodulators Market Growth



Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *